GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Antengene Corp Ltd (FRA:722) » Definitions » Pretax Margin %

Antengene (FRA:722) Pretax Margin % : -274.82% (As of Jun. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Antengene Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Antengene's Pre-Tax Income for the six months ended in Jun. 2024 was €-21.39 Mil. Antengene's Revenue for the six months ended in Jun. 2024 was €7.78 Mil. Therefore, Antengene's pretax margin for the quarter that ended in Jun. 2024 was -274.82%.

The historical rank and industry rank for Antengene's Pretax Margin % or its related term are showing as below:

FRA:722' s Pretax Margin % Range Over the Past 10 Years
Min: -2278.58   Med: -863.5   Max: -375.61
Current: -956.07


FRA:722's Pretax Margin % is ranked worse than
72.95% of 1013 companies
in the Biotechnology industry
Industry Median: -148.6 vs FRA:722: -956.07

Antengene Pretax Margin % Historical Data

The historical data trend for Antengene's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Antengene Pretax Margin % Chart

Antengene Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Pretax Margin %
Get a 7-Day Free Trial - - -2,278.81 -375.61 -863.49

Antengene Semi-Annual Data
Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only -267.71 -430.44 -303.66 7,694.88 -274.82

Competitive Comparison of Antengene's Pretax Margin %

For the Biotechnology subindustry, Antengene's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Antengene's Pretax Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Antengene's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Antengene's Pretax Margin % falls into.



Antengene Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Antengene's Pretax Margin for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Margin=Pre-Tax Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-74.64/8.644
=-863.49 %

Antengene's Pretax Margin for the quarter that ended in Jun. 2024 is calculated as

Pretax Margin=Pre-Tax Income (Q: Jun. 2024 )/Revenue (Q: Jun. 2024 )
=-21.389/7.783
=-274.82 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Antengene  (FRA:722) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


Antengene Pretax Margin % Related Terms

Thank you for viewing the detailed overview of Antengene's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Antengene Business Description

Traded in Other Exchanges
Address
1065 West Zhongshan Road, Suites 1206-1209, Block B, Zhongshan SOHO Plaza, Changning District, Shanghai, CHN
Antengene Corp Ltd is a clinical-stage biopharmaceutical company focused on oncology medicines. The company produces drugs such as selinexor, eltanexor, verdinexor, and other products. It also engages in the discovery, development, manufacturing, and commercialization of first-in-class therapeutics for the treatment of hematologic malignancies and solid tumors. Geographically it operates in Chinese Mainland, Hong Kong, Macao and Taiwan and Overseas.

Antengene Headlines

No Headlines